Author(s): Binder DC, Fu YX, Weichselbaum RR, Binder DC, Fu YX, Weichselbaum RR, Binder DC, Fu YX, Weichselbaum RR
Abstract Share this page
Abstract Combining radiation and immune checkpoint blockade provides synergistic antitumor responses in animal models and a small subset of patients. New preclinical data have provided mechanistic insight into this treatment interaction and identification of therapeutic targets to optimize this approach. Copyright © 2015 Elsevier Ltd. All rights reserved.
This article was published in Trends Mol Med
and referenced in Immunotherapy: Open Access